Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amphastar Pharmaceuticals, Inc. - Common Stock (NQ:AMPH)

25.88 +0.17 (+0.66%)
Streaming Delayed Price Updated: 11:57 AM EDT, Jun 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 159,624
Open 25.61
Bid (Size) 25.86 (2)
Ask (Size) 25.88 (1)
Prev. Close 25.71
Today's Range 25.26 - 25.95
52wk Range 22.64 - 53.95
Shares Outstanding 48,081,433
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Small-Cap Stocks Walking a Fine Line
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
Via StockStory
Evolent Health, Amphastar Pharmaceuticals, Iridium, and Magnite Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices rebounded (Nasdaq +2.0%, S&P 500 +2.0%) as President Trump postponed the planned 50% tariff on European Union imports,... 
Via StockStory
Topics Artificial Intelligence Government Stocks
Exposures Artificial Intelligence Political Tariff

Performance

YTD
-28.8%
-28.8%
1 Month
+6.0%
+6.0%
3 Month
-19.9%
-19.9%
6 Month
-42.0%
-42.0%
1 Year
-38.3%
-38.3%

More News

Read More
Generic Pharmaceuticals Stocks Q1 In Review: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs Peers
Via StockStory
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
Via ACCESS Newswire
Earnings Scheduled For May 7, 2025
Via Benzinga
Earnings Outlook For Amphastar Pharma
Via Benzinga
AMPHASTAR PHARMACEUTICALS INC (NASDAQ:AMPH) – A Potentially Undervalued Stock Worth Watching
Via Chartmill
This Target Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday
Via Benzinga
Amphastar Pharmaceuticals to Present at the 2025 Bank of America Health Care Conference
Via ACCESS Newswire
Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q1 Sales Targets
Via StockStory
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025
Via ACCESS Newswire
Amphastar Pharmaceuticals Inc (NASDAQ:AMPH): A Closer Look at Dividend Potential
Via Chartmill
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7th, 2025
Via ACCESS Newswire
2 Healthcare Stocks on Our Watchlist and 1 to Be Wary Of
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Generic Pharmaceuticals Stocks Q4 Teardown: Viatris (NASDAQ:VTRS) Vs The Rest
Via StockStory
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
AMPHASTAR PHARMACEUTICALS IN (NASDAQ:AMPH) is an undervalued gem with solid fundamentals.
Via Chartmill
2 Safe-and-Steady Stocks with Solid Fundamentals and 1 to Think Twice About
Via StockStory
Exposures Ethanol
2 Reasons to Like AMPH and 1 to Stay Skeptical
Via StockStory
Topics Supply Chain
Exposures Supply Chain
Amphastar Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference
Via ACCESS Newswire
International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance Award
Via ACCESS Newswire
AMPHASTAR PHARMACEUTICALS IN (NASDAQ:AMPH), an undervalued stock with good fundamentals.
Via Chartmill
Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks
Via StockStory
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare Conference
Via ACCESS Newswire
Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers
Via StockStory
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Specialty Pharma Amphastar Stock Falls On Lower Than Expected Q4 Earnings, Analyst Sees Competitive Headwinds
Via Benzinga

Frequently Asked Questions

Is Amphastar Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Amphastar Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Amphastar Pharmaceuticals, Inc. - Common Stock trade on?
Amphastar Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Amphastar Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Amphastar Pharmaceuticals, Inc. - Common Stock is AMPH on the Nasdaq Stock Market
What is the current price of Amphastar Pharmaceuticals, Inc. - Common Stock?
The current price of Amphastar Pharmaceuticals, Inc. - Common Stock is 25.88
When was Amphastar Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Amphastar Pharmaceuticals, Inc. - Common Stock was at 06/02/25 11:57 AM ET
What is the market capitalization of Amphastar Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Amphastar Pharmaceuticals, Inc. - Common Stock is 1.24B
How many shares of Amphastar Pharmaceuticals, Inc. - Common Stock are outstanding?
Amphastar Pharmaceuticals, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.